Archives
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Monomethyl Auristatin E: ADC Payloads for Precision Cance...
2025-09-30
Monomethyl auristatin E (MMAE) is revolutionizing targeted cancer therapy as a potent antimitotic agent for antibody-drug conjugates (ADCs). This article breaks down experimental workflows, advanced use-cases, and troubleshooting strategies to maximize the impact of MMAE in cancer research and drug development.
-
Bortezomib (PS-341): Decoding Proteasome Inhibition in Py...
2025-09-29
Explore how Bortezomib (PS-341), a reversible proteasome inhibitor, uniquely advances our understanding of 20S proteasome inhibition and its impact on pyrimidine salvage pathway regulation in cancer therapy research. This article provides an in-depth, mechanistic analysis distinct from prior content and integrates the latest findings on mTORC1-mediated metabolic control.
-
Cy3 TSA Fluorescence System Kit: Redefining Spatial Quant...
2025-09-28
Explore how the Cy3 TSA Fluorescence System Kit revolutionizes signal amplification in immunohistochemistry by enabling quantitative, spatially resolved detection of low-abundance biomolecules within complex tumor microenvironments. Discover advanced strategies for multiplex fluorescence microscopy and the integration of TSA with emerging cancer metabolism research.
-
Metronidazole: Advanced Insights into OAT3 Inhibition and...
2025-09-27
Explore the multifaceted role of Metronidazole as a nitroimidazole antibiotic and potent OAT3 inhibitor. This article provides a unique scientific perspective on drug-drug interaction modulation and advanced applications in anaerobic bacteria targeting and protozoa treatment research.
-
Clozapine N-oxide (CNO): Transforming Chemogenetic Dissec...
2025-09-26
Discover how Clozapine N-oxide (CNO) revolutionizes neuroscience research as a selective chemogenetic actuator. This article uniquely explores its application in modulating retino-amygdala circuits and anxiety mechanisms, offering advanced insights for GPCR signaling and neuronal activity studies.
-
Canagliflozin Hemihydrate: Unraveling SGLT2 Inhibition in...
2025-09-25
Explore the unique role of Canagliflozin hemihydrate as a small molecule SGLT2 inhibitor in dissecting glucose homeostasis pathways and metabolic disorder mechanisms. This article provides a systems biology perspective that extends beyond traditional diabetes research.
-
Anti Reverse Cap Analog (ARCA): Unlocking Precision mRNA ...
2025-09-24
Discover how Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, empowers researchers with precision mRNA capping for enhanced translation and metabolic regulation. This article uniquely connects ARCA's biochemical mechanism to mitochondrial enzyme control, illuminating new frontiers in synthetic mRNA therapeutics.
-
Bufuralol Hydrochloride in Human Intestinal Organoid Models
2025-09-23
Explore the applications of Bufuralol hydrochloride as a non-selective β-adrenergic receptor antagonist in advanced human organoid systems for cardiovascular pharmacology research. This article provides rigorous scientific context for β-adrenergic modulation studies using cutting-edge in vitro models.
-
First investigation of numerous membered ether linked macroc
2025-03-03

First, investigation of numerous 12-14-membered ether-linked macrocycles revealed that smaller motifs were most lipophilic efficient. Compound (3) (12-membered macrocycle) exhibited good cellular potencies (ALK IC50 = 1.0 nM; ALK-L1196 M IC50 = 20 nM) and the highest LipE (4.4) with picomolar bindin
-
The functional observations from the
2025-03-03

The functional observations from the present study are based on neoplastic parp inhibitors (HSY), and comparative expressions between normal salivary and pleomorphic adenoma tissues. However, there is a paucity of information on AhR expression and function in normal salivary gland, not neoplastic,
-
Role of APPL in endosomal signaling
2025-03-03

Role of APPL in endosomal signaling pathways Endosomes consist of distinct membrane subdomains within individual organelles and assist in the translation of extracellular stimuli via cytoplasmic transduction cascades to the nucleus [3], [74]. Endosomal abnormalities are associated with the pathogen
-
AdipoRon acts on the anti diabetic effects of
2025-03-03

AdipoRon acts on the anti-diabetic effects of adiponectin, exhibiting its effect through the activation of AMPK and PPARα pathways via AdipoR1 and AdipoR2, respectively [23]. AdipoR activation is a promising treatment for diabetes, nonalcoholic fatty liver disease, and cardiovascular disease, demons
-
Although the immobilization by histidine tag exhibits effect
2025-03-03

Although the immobilization by histidine tag exhibits effectiveness in oriented enzyme immobilization, it still faces some challenges [31]. On one hand, some unnecessary metal-binding proteins that interfere with the combination between the target protein and the supports or the additional interacti
-
VTX-2337 receptor It is well known that the thymus plays
2025-03-03

It is well known that the thymus plays an important function in the complex pathogenesis and perpetuation of MG. We compared resistin levels between patients with MG with or without thymoma and found that those with thymoma had higher levels than those without thymoma. It has been previously recogni
-
Accumulating data suggest that ROS trigger autophagy but in
2025-03-03

Accumulating data suggest that ROS trigger autophagy but, in turn, autophagy reduces ROS levels [23]. Our results are in agreement because 27-OH mediated autophagy induction interms of LC3 II formation and Beclin 1 protein expression was suppressed by treating the promonocytic cells with the antioxi
16464 records 13/1098 page Previous Next First page 上5页 1112131415 下5页 Last page